Wanbury Stock Forecast for 2023 - 2025 - 2030

Updated on 05/18/2024

Stock Rating
-8
Price Target
Rp0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
-8
Downside
-100.00%
Analysts
0
Price Target
Rp0.00
-

Wanbury Fair Value Forecast for 2023 - 2025 - 2030

Wanbury's Price has seen growth In the last year, going from Rp0.00 to Rp0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach Rp0.00 – an increase of 100.00%. For the next five years, the forecast is forFair Value to grow by 100.00%.

2026 Fair Value Forecast
Rp0.00
2027 Fair Value Forecast
Rp0.00
2028 Fair Value Forecast
Rp0.00
2029 Fair Value Forecast
Rp0.00
2030 Fair Value Forecast
Rp0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DIVISLAB Stock Forecast Divi's Laboratories Hold 18
Rp3.91k Buy/Sell Rp3.30k -13.96%
IPCALAB Stock Forecast Ipca Laboratories Hold 18
Rp1.30k Buy/Sell Rp987.00 -11.92%
524558 Stock Forecast Neuland Laboratories Buy 18
Rp6.25k Buy/Sell Rp5.88k 32.70%
524348 Stock Forecast Aarti Drugs Outperform 16
Rp490.00 Buy/Sell Rp612.50 10.61%
506690 Stock Forecast Unichem Laboratories - 8
Rp554.95 Buy/Sell Rp355.00 -100.00%

Wanbury Revenue Forecast for 2023 - 2025 - 2030

Wanbury's Revenue has seen growth In the last three years, going from Rp3.67B to Rp5.00B – a gain of 35.98% The next year, 0 experts forecast that Wanbury's Revenue will decrease by 9.10%, reaching Rp4.54B. In 2030, professionals predict that Wanbury's Revenue will decrease by 8.12%, reaching Rp4.59B.

2024 Rev Forecast
Rp4.54B
2025 Rev Forecast
Rp4.38B
2026 Rev Forecast
Rp4.61B
2027 Rev Forecast
Rp4.75B
2028 Rev Forecast
Rp4.68B
2029 Rev Forecast
Rp4.58B
2030 Rev Forecast
Rp4.59B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
524735 Stock Forecast Hikal Buy 18
Rp298.05 Buy/Sell Rp328.00 10.72%
SOLARA Stock Forecast Solara Active Pharma Sciences Outperform 9
Rp486.65 Buy/Sell Rp395.00 -28.08%
532637 Stock Forecast Mangalam Drugs & Organics - 0
Rp117.75 Buy/Sell Rp0.00 -100.00%

Wanbury Dividend per Share Forecast for 2023 - 2025 - 2030

Wanbury Free Cash Flow Forecast for 2023 - 2025 - 2030

Wanbury EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Wanbury's EBITDA has fallen from Rp231.78M to Rp214.11M – a 7.62% decrease. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach Rp243.30M – an increase of 13.63%. The Wanbury forecast is for EBITDA to reach Rp275.36M or grow by 28.60%.

2024 EBITDA Forecast
Rp0.24B
2025 EBITDA Forecast
Rp0.26B
2026 EBITDA Forecast
Rp0.30B
2027 EBITDA Forecast
Rp0.27B
2028 EBITDA Forecast
Rp0.26B
2029 EBITDA Forecast
Rp0.26B
2030 EBITDA Forecast
Rp0.28B

Wanbury EBIT Forecast for 2023 - 2025 - 2030

Wanbury's EBIT has decreased In the last three years, from Rp137.74M to Rp118.60M – a 13.90% drop. For next year, the 0 analysts predict EBIT of Rp150.61M, which would mean an increase of 26.99%. Over the next seven years, the pros' prediction is EBITof Rp186.64M, which would mean a seven-year growth forecast of 57.37%.

2024 EBIT Forecast
Rp0.15B
2025 EBIT Forecast
Rp0.17B
2026 EBIT Forecast
Rp0.22B
2027 EBIT Forecast
Rp0.18B
2028 EBIT Forecast
Rp0.17B
2029 EBIT Forecast
Rp0.17B
2030 EBIT Forecast
Rp0.19B

Wanbury EPS Price Prediction Forecast for 2023 - 2025 - 2030

Wanbury's EPS has seen growth In the last year, going from Rp-2.47 to Rp0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach Rp0.00 – an increase of 100.00%. For the next five years, the forecast is forEPS to grow by 100.00%.

2026 EPS Forecast
Rp0.00
2027 EPS Forecast
Rp0.00
2028 EPS Forecast
Rp0.00
2029 EPS Forecast
Rp0.00
2030 EPS Forecast
Rp0.00